THC Biomed Intl Ltd. THCBF
OTC PK
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -12.52% | 35.86% | 40.09% | -- | -- |
| Total Depreciation and Amortization | 24.03% | -9.18% | -6.26% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.97% | -72.98% | -54.81% | -- | -- |
| Change in Net Operating Assets | 808.17% | 376.74% | -103.12% | -- | -- |
| Cash from Operations | 65.25% | 28.88% | 4.53% | -- | -- |
| Capital Expenditure | 63.15% | 18.05% | -47.90% | -- | -- |
| Sale of Property, Plant, and Equipment | -92.97% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,974.36% | -1,056.18% | -79.17% | -- | -- |
| Cash from Investing | -111.28% | 604.18% | 609.93% | -- | -- |
| Total Debt Issued | -23.75% | -27.60% | -33.92% | -- | -- |
| Total Debt Repaid | 14.83% | -375.46% | -319.19% | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -96.82% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2,588.14% | -232.62% | -190.23% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -232.42% | 61.13% | -428.37% | -- | -- |